About Mohs Micrographic Surgery
Welcome to Macaione and Papa Dermatology Associates. Mohs surgery uses a sophisticated microscopic method to examine, locate and remove cancerous cells in the skin. Mohs Micrographic Surgery ensures the highest possible cure rate.
We understand the term “skin cancer” can be a frightening one. Our staff will make certain that you receive friendly compassionate care as well as complete information about your condition and treatment.
What is Skin Cancer?
Skin cancer is the most common cancer in the United States with over one million cases diagnosed each year. Like cancer in other organs of the body, skin cancer results from uncontrolled, abnormal growth of cells and is caused by sunburns, ultraviolet light, heredity, or exposure to X-Rays. When the cells in the skin begin to grow in an abnormal fashion, a tumor will result. This tumor may be benign or malignant.
A malignant tumor is considered a cancer and should be removed to prevent the possibility of invasion and destruction of surrounding normal tissue. While most skin cancers do not spread to other parts of the body, they frequently invade surrounding normal tissue, causing extensive destruction of skin.
The most common types of skin cancer treated with Mohs Micrographic Surgery are Basal Cell Carcinoma and Squamous Cell Carcinoma.
What is Mohs?
After a skin cancer diagnosis has been made, the appropriate treatment option may be Mohs Micrographic Surgery. Mohs is a state-of-the-art-treatment for skin cancer that relies on the precision and accuracy of a microscope to trace the path of the tumor and ensure removal of skin cancer down to its roots.
Advantages of Mohs Surgery:
- Offers highest cure rate up to 99%
- Most precise cancer removal
- Lowest chance of re-growth
- Spares normal skin in removal
- Minimizes scarring
Which Cancers need Mohs?
Mohs is most often used to treat Basal and Squamous Cell Carcinoma when:
- Cancer is large
- Edges cannot be clearly defined
- Important to preserve surrounding skin
- Recurring or aggressive skin cancer
- Patient has a deficient immune system